Deputy Director, Tuberculosis Drugs & Diagnostics

The Foundation

We are the largest nonprofit fighting poverty, disease, and inequity around the world. Founded on a simple premise: people everywhere, regardless of identity or circumstances, should have the chance to live healthy, productive lives. We believe our employees should reflect the rich diversity of the global populations we aim to serve. We provide an exceptional benefits package to employees and their families which include comprehensive medical, dental, and vision coverage with no premiums, generous paid time off, paid family leave, foundation-paid retirement contribution, regional holidays, and opportunities to engage in several employee communities.

As a workplace, we're committed to creating an environment for you to thrive both personally and professionally.

Our Global Health (GH) division harnesses advances in science and technology to save lives in developing countries. We focus on the health problems that have a major impact in developing countries but get too little attention and funding. Where tools exist, we support sustainable ways to improve their delivery. Where they don't, we invest in research and development of new interventions, such as vaccines, drugs, and diagnostics.

Our work in infectious diseases focuses on strategies to fight and prevent HIV/AIDS, malaria, tuberculosis (TB), neglected tropical diseases, enteric and diarrheal diseases, pneumonia and maternal, newborn and child health. Our TB and HIV work is combined under a joint TB/HIV Program Strategy Team (PST) which focuses on research, development and delivery of new products and tools. TB is the top infectious disease killer.

In 2023, there were an estimated 10.8 million new TB cases worldwide. The goal of the tuberculosis (TB) Program Strategy is to accelerate the reduction in TB incidence globally through innovative discovery and development of new tools and approaches. The TB Program Strategy Team (PST) is responsible for R&D investments targeting more effective TB interventions including vaccines, diagnostics, and drugs.

Current TB drug regimens are too long and complicated by drug resistance. The aim of the TB Drug Initiative is to deliver simpler, safer, markedly shorter pan-TB drug regimens leading to improved outcomes and lower incidence. The TB Drug Initiative is responsible for setting strategy and managing an end-to-end drug portfolio, collaborating with internal and external partners, and overseeing product development from discovery to the introduction of new treatment regimens in Global Health markets.

Accessible, low-cost, high-quality diagnostics are essential for early TB detection and for the success of any improved TB treatment regimen. The TB Diagnostics R&D portfolio focuses on near point-of-care (nPOC) tests, distributable PCR kits, and affordable screening tools to expand testing and enable same-visit treatment initiation. We work in close partnership with the Enterics, Diagnostics, Genomics & Epidemiology (EDGE) team to define and manage a research and development portfolio of TB diagnostics and devices.

You shape and manage the execution of the TB Drugs strategy, work in partnership with the EDGE team to shape and manage a TB Diagnostics research and development strategy, and partner with the TB Delivery team to drive the introduction of new TB drugs and diagnostics. You manage relationships with grantees, contractors, and key partners to achieve the foundation's desired impact, provide project briefings/updates to foundation leadership, and represent the foundation in meetings with external stakeholders and at scientific conferences/workshops.

Lead, shape, and guide strategy to support the foundation's large and diverse TB drugs portfolio, including goal setting, strategic prioritization across product concepts, advancement of lead candidates, clinical development planning, and impact measurement of product solutions towards approved strategic objectives.

Oversee the design and implementation of a portfolio of high-impact TB drugs grants, including support to robust systems that ensure grantee collaboration, balance in the portfolio, and effective annual planning.

Identify critical intersections between the TB Drugs and Diagnostics strategies and partner with the EDGE and TB Delivery teams to identify priority initiatives and investments.

Support and manage a TB Diagnostics R&D technical expert, in collaboration and coordination with the EDGE team.

Identify, cultivate, and manage robust partnerships within a broad and diverse global eco-system to achieve impact (i.e., pharma, biotech, vaccine manufacturers, academia, product development partners, and governments).

Act as a leadership and thought partner to grantees, helping them achieve strategic objectives.

Lead and guide the TB Drugs team's efforts in optimizing the level of engagement required for specific team and grantee support.

Provide strategic guidance in crafting grants or contracts, helping to ensure that…